chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I started to feel under the weather, not feeling well generally. It felt like I was getting sick. It was a different feeling. I began to have headaches, fever, fatigue, body aches and vertigo. It got progressively worse over the next 3 to 4 days. I took an at home COVID-19 test and it was positive. I experienced loss of appetite but attempted drink lots of fluid. After the symptoms persisted for almost a week, I went to the doctor on August 09, 2022. I was still testing positive. They prescribed a dose of steroids prednisone that I took for several days. I also had developed a secondary respiratory infection that was starting to go into my bronchial tube and prescribed a round of antibiotics cefdinir and I almost immediately started to feel better. The vertigo lasted for another couple of weeks, but I have since completely recovered.
approx 10min pt passed out & fell to floor w/sz-like activity;pt immed regained consciousness;parent took pt @ 1PM to MD for eval;MD stated pt just passed out;
Apprx 8 hours after booster shot, I experienced chest tightness and a few sharp pains in chest area. For the next 24 hrs+ chest area remained tight, I was short of breath and my heart felt like it was beating fast.  Symptoms felt worst about 24 hours after shot was given, at which point I consulted a teledoctor service who told me these were not symptoms of the vaccine and that I should be seen in person by someone to check my vitals. I went to an urgent care where they confirmed a fever, a negative COVID test, and did an EKG. EKG was normal but told me that I needed to go to the ER to rule out blood clot or PC. Pain was still mild at this point, short of breath, and migraine but still told to go to ER. The ER did another EKG and X-ray. X-ray showed mild lung inflammation, EKG indicated possible long QT interval. Given my daily medication, they thought this was probably unrelated to the booster and referred me to my primary to double-check in a day (3 days later, EKG was normal). ER gave me Tylenol which relieved headache but not chest tightness, and I was sent home. Symptoms lessened over the next two days but still present. No symptoms 12/13
Post 1 st vaccine symptoms started 12 hrs later. Stayed in bed 36 hrs w/chills, sweats, sore throat, brain fog, severe chronic leg and body pain, bad dreams, disoriented loopy. Post 2nd vaccine worsened brain fog, heavy menstrual cycle, forgetfulness, loss of short term memory, loss of interest in daily activities, forget to pay bills and deadlines relying on notes and calendar. Uncomfortable Leg pain at vein sites, tingling and vibrating up n down legs causing soreness.  Tiredness and falling sleep very easily at night. Anxious to get to bed!!!
Severe UTI symptoms . Went to minute clinic. Got negative for UTI in store urine test. When send to culture, it had little step. Got antibotics in 2days. By the time i got my  symptims went down. I took antibiotics for 3 days .  I still have uti sysmptoms once a day. Not sure what it is.. i had uti before in my life but this time the symptoms are different and very bad . Over the counter medication is of no  use .
Patient was vaccinated on 4/1/21 and 4/25/21, so was fully vaccinated when testing positive for COVID-19 on 9/26/21.
This spontaneous report was received from a physician assistant via a company representative and refers to a 60-year-old female patient. The patient's pertinent medical history, concomitant medications and drug reactions or allergies were not reported. In approximately 2016 (reported as "roughly a year ago"), the patient was vaccinated with ZOSTAVAX (19400 plaque-forming units, PFU) subcutaneously (dose, anatomical location, lot # and expiration date were not reported), for prevention of herpes zoster. On 15-MAY-2017, the patient had gotten shingles after being vaccinated with with ZOSTAVAX. The patient sought medical attention and saw a physician, who gave her acyclovir 800 mg, for 7 days as a treatment for her shingles. The outcome of shingles was unknown at the time of the report. No product quality complaint (PQC) was involved. The causality assessment between the event of shingles and the vaccination with ZOSTAVAX was not reported. Additional information has been requested.
roof of my mouth was burned; hallucinations; extreme vomiting; dizzy; fever; nausea; roof of my mouth was burned; have been unable to eat anything due to the pain; This is a spontaneous report from a contactable consumer (patient). A 29-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: FF2588), via an unspecified route of administration, administered in Arm Left on 24Sep2021 11:00 (at the age of 29years) as dose number unknown, single for Covid-19 immunization. The patient was not pregnant at the time of vaccination. Medical history included anemia, blood clots, ectopic pregnancy, Known allergy: Eggs, Mushrooms. The patient's concomitant medications were not reported. The patient previously took Tylenol and experienced allergy. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. It was reported that on 25Sep2021 (also reported as the 2nd day)), the patient experienced extreme vomiting, dizzy, hallucinations, fever were all expected until day 3. The patient sought medical attention for the nausea. On day 3 (reported as 27Sep2021), the roof of mouth was burned, and patient had not eaten anything, have been unable to eat anything due to the pain. On Day 4 other symptoms dissipated, the remaining symptom is that of the burn on the roof of mouth that does not ease with saltwater rinses or anything. The patient scheduled dentist appointment to see if there is anything that can be done on 28Sep2021. Dentist visit scheduled for 29Sep2021 at 10:30 a.m. The adverse events resulted in Doctor or other healthcare professional office/clinic visit. AE treatment: nausea medication, pending dentist visit at 10:30. The outcome of events was not recovered.  Follow-up attempts are completed. No further information is expected.
A report has been received from a pharmacist concerning an adult, female patient. No information regarding relevant history, concomitant disease and concomitant medications were provided. The patient received FLUMIST QUADRIVALENT (intranasal) two weeks ago during 2014. It was reported that recently patient was tested positive for influenza (not sure which strain). Patient was still symptomatic. The reporter considered the event to be non-serious.
Brain fog; Extreme lethargy; Body aches; Fine rash on head/neck/extremities; Chills; This is a spontaneous report from a contactable healthcare professional, the patient. A 41-years-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: UNKNOWN) via an unspecified route of administration on left arm on 18Mar2021 at 11:00 (at the age of 41-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 diagnosed prior to vaccination. Patient had no allergy to medications, food, or other products. Concomitant medications included tazorac 0.1% (MANUFACTURER UNKNOWN) on face only from an unknown date for unknown indication. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Since the vaccination, the patient had not been tested for COVID-19. On 19Mar2021 at 00:00, the patient experienced mental confusion, lethargy, chills, ache and fine rash on head, neck and extremities. No treatment was received by the patient for the adverse events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of events mental confusion, lethargy, chills, ache, rash were not resolved at the time of this report.   Information about lot/batch number cannot be obtained. No further information is expected.
My arm was extremely sore and I had a fever for the following two days after the vaccine but then it went away. I was feeling back to normal until yesterday, my arm got very red and swollen and today it?s hard, hot, and hurts to the touch. I?ve also been extremely tired the last two days
Patient complained of shortness of breath, chest pain, and chest tightness after about 1 minute following vaccine. She was given Epi 0.3, Benadryl 25mg, and Solumedrol 125mg. She was transported to ER and was released after symptom resolution and normal EKG at the Hospital.
Patient returned to department with complaints of fever of 101 degrees, dizziness, severe occipital headache, nausea, and she was cold and clammy. Our OcMD notified and was instructed to send patient to ER.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 38-year-old male patient received BNT162b2 (BNT162B2), as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Positive, notes: COVID 19 Treatment; (Jul2022) Negative, notes: Symptoms went away a few days later and tested negative; (15Jul2022) Positive, notes: A few days later, experienced new symptoms and tested positive again. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: Patient was not received other medication in two weeks. Paxlovid (anti viral) treatment started on 08Jul2022 and stopped on 12Jul2022. Patient was infected with covid19. Completed course of Paxlovid. Symptoms went away a few days later and tested negative. A few days later, experienced new symptoms and tested positive again. He experienced Paxlovid rebound. Patient did not receive treatment for AE but recovered with lasting effects.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Patient experienced burning and redness at site of injection initially. Vaccine was almost a month ago and patient is experiencing continued burning and a lump at the injection site.
This spontaneous report as received from a pharmacist refers to a 64 year old female patient. The patient had no known drug reactions/allergies. On 30-MAY-2013 the patient was vaccinated with a 0.65ml dose of ZOSTAVAX (lot # H022153, expiration date 18-MAR-2014), subcutaneously, at right arm. Concomitant therapies included LANTUS, TRADJENTA, acetaminophen, NORCO, atenolol, CELEBREX, glipizide, LIPITOR, K-DUR, trazodone hydrochloride, PAXIL, NEURONTIN, metformin and FOSAMAX. On 02-JUN-2013, the patient noticed red, warm to touch area "about the size of a half dollar" on her right arm where she had received the ZOSTAVAX vaccination. The patient did not sought medical attention. The patient was still experiencing an injection site reaction and was not fully recovered. The patient present status was recovering. Additional information has been requested.
pt experiencing rash to trunk, neck, back, swelling to lower lip and left toes. pt received 50 mg po benadryl, 50 mg iv benadryl, epi 0.3 mg IM left thigh, iv, ns 1 liter IV
Left arm first swelled at injection site. Was very sore then moved and swelled in forearm down to elbow. I hurt all over especially my neck. Doctors nurse told me to put ice on it and take Benadryl. By second night had fever and chills. The morning of 10/7/04, my arm was red and swollen . Had Dr give me cephalexin 500 mg x 7 days. Problem with left arm.
Received vaccine through Employee Health at hospital on 8/3/09. Arm swelled about two to three times normal size and turned red and hot; 1st ER visit diagnosed with adverse reaction to Tdap as well as cellulitis. Given oral antibiotic and pain killer. Waited 3 days for improvement before returning to ER. 8-10-09 return to ER for dose of Vancomycin; diagnosed with staph infection from the shot; arm has swelled more and swelling has increased to shoulder, down the shoulder blade, and up the neck. 8-12-09 return to ER; admitted for 3 days worth of Vancomycin; continued redness; swelling decreasing; arm still numb and painful to touch. Infectious disease Dr clears me of staph yet placed me on vitamin B6 for nerve health. Still unable to lift weight in left arm and painful; refer to neurologist. Nerve test results are good; no permanent damage; still pain and unable to lift weight; unable to work bc of injury. 10/2/09 Received medical records for date of service 8/10/09 to 8/12/09. DX: Cellulitis left upper arm and forearm.  Presenting SX: chief c/o left arm pain, swelling, erythema tracking up to her neck and back. Tetanus vaccine 5 days prior. PO abx given but pain, swelling and erythema got worse. Pt tx with IV abx.   ICD9 codes: 682.3, 041.12, V0254
?febrile seizure approx 3 hrs p/DTP administered continued w/fever 103 x 2 days; several episodes of vomiting on 3FEB92;
This spontaneous report as received from a other health professional refers to a patient of unknown age and gender. No current condition or medical history was reported. On 16-OCT-2014, the patient was vaccinated with an expired dose of ZOSTAVAX, subcutaneous injection (lot number: unknown, expiration date: 12-OCT-2014) 0.65 ml once subcutaneously. No concomitant therapy was reported. At the time of the report, the patient experienced no adverse effects. The outcome of the events was not reported. Action taken with the suspect product and causality was not provided. Additional information has been requested.
This spontaneous report as received from a medical assistant refers to a 2 year old patient of unknown gender. The patient's concurrent conditions, medical history, concomitant medications, drug reactions and allergies were not reported. On 26-SEP-2018, the patient was vaccinated with improperly stored dose of VAQTA ped 0.5 ml vial (dose, frequency and route were not reported) (lot # R009953, expiry date: 12-JUN-2019) for prophylaxis. The vaccine was exposed to the temperature of 32.21 degree Fahrenheit (°F) (32F to 35 F) for 3.5 hours from 06-SEP-2018. Previous excursion was 50.37°F for 4.5 hours as recorded by a data logger. No adverse effect was reported. No product quality complaint was involved. This is one of the several reports received from the same reporter source. Sender's Comments: US-009507513-1809USA002868: Original Case: 1809USA002868; US-009507513-1902USA009324: Original Case: 1902USA009323; US-009507513-1902USA009325: Original Case: 1902USA009323; US-009507513-1902USA009326: Original Case: 1902USA009323.
Red at injection site, warm and sore to touch, with redness progressing 4 inches down arm.  Chills to the point of shivering for 48 hours. Temperature of 2 degrees above normal range for me. Severe headache at base of skull and between eyes and sensitivity to bright light lasting 48 hours. Was able to stay awake for 12 hours after the shot before symptoms started, then unable to stay awake for more than 7 hours during those 48 hours of symptoms.
This spontaneous report was received from a Licensed Practical Nurse and refers to a 13-year-old patient of unknown gender. No information was provided regarding the patient's medical history, concurrent conditions, drug reactions, allergies or concomitant medications. On  29-JUL-2021, the patient was vaccinated for prophylaxis with HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) lot # T025370 with expiration date on 01-DEC-2022 (strength, dose number, anatomical location, route of administration, lot number and expiration date were not reported), that underwent a temperature excursion that was not called because a digital data logger, bellow 2°C (1.1°C) for 3 hours 9 minutes and 0 seconds, without previous temperature excursion. No adverse events were reported
Information has been received from a physician concerning himself over 60 year old who was vaccinated with a dose of ZOSTAVAX (Merck) (specific date not given). Subsequently the patient experienced flu like symptoms and had a fever of 102 at that weekend. He felt better a couple days later on unspecified therapies and recovered a couple days after receiving ZOSTAVAX (Merck). He did not seek medical attention. Follow up information was received from the physician who reported himself did not have illness at time of vaccination and medical history or drug allergy. There was no relevant diagnostic laboratory test. He was vaccinated with a dose of ZOSTAVAX (Merck) on 12-FEB-2009. At 12:00 on 15-FEB-2009 he experienced fever for 102 and chills for 48 hours. Additional information is not expected.
This spontaneous report as received from a nurse refers to unspecified patients of unknown age and gender. On an unknown date the patients were vaccinated with a improperly stored doses of VAQTA (lot# not reported). This is one of several reports received from the same source. Additional information has been requested.
Patient present to clinic 24 hours after receiving vaccinations with rash on left arm, rash also on right side of neck, wrapped around the back of the neck and also the front of the neck.
pain in the injection site for few days; pain starts to increase in my arm and radiate down to my armpit; swollen lymph nodes; felling of unwell; sever muscle pain; redness/redness on the right side of the breast; pain starts to increase in my arm and radiate down to my armpit; This is a spontaneous report from a contactable consumer. A 47-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: 9269), via an unspecified route of administration, on 07Feb2021 at 14:00 (at the age of 47-year-old), as 1st dose, single for COVID-19 immunisation. The patient's medical history included thyroid issue. Patient had no known allergies. Concomitant medication in two weeks included levothyroxine. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Feb2021, at 14:30, 30 minutes after vaccination, the patient experienced pain in the injection site, which lasted for few days. Pain started to increase in her arm and radiated down to her armpit, with swollen lymph nodes and redness. Patient experienced a felling of unwell, with sever muscle pain and the injection area was very painful. Patient had redness on the right side of the breast. Patient enquired about the outcome or treatment for this vaccine side effect. The clinical outcome of all the events was not recovered.  No follow-up attempts are possible, information on batch numbers cannot be obtained.
Chest pain and elevated heart rate (mid 80s BPM). Normal is 60 BPM. Chest diminished over days but was still noticeable about 5 days after injection.
No symptoms reported. No further AE details; Date of excursion: 3/2/2023; This spontaneous report has been received from a pharmacist, regarding a 1-years-old patient of unknown gender. The patient's pertinent medical history, previous drug reactions or allergies and concomitant medications were not reported.  On 02-MAR-2023, doses of varicella virus vaccine live (Oka/Merck) (VARIVAX) injection (lot number: W0252273, which was changed to the valid lot number W025273, with an expiration date on 10-AUG-2024) underwent a temperature excursion of 70 degrees Fahrenheit (F), for 9 minutes. No previous temperature excursions were reported.   On 12-JUN-2023, the patient was vaccinated with the improperly storage dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) injection, at a dose of 0.5 milliliters (ml) once as prophylaxis (lot number: W0252273) (strength, route and anatomical location of administration were not reported) (Product storage error). No symptoms or further adverse events were reported.   This case is one of multiple reports from the same reporter.; Sender's Comments:  US-009507513-2306USA007844:
This spontaneous report as received from a physician refers to a patient of unknown age. On an unknown date the patient was vaccinated with a dose of expired PNEUMOVAX 23 (lot # J004058; exp date: October 2014)(dose, frequency were not reported). No adverse symptoms were reported. The physician stated that the PNEUMOVAX 23 did not have any previous temperature excursions. Additional information has been requested.
Information has been received from a registered nurse concerning a 6 year old male who in approximately 1996 was vaccinated with varicella vaccine. On 07/05/2001 it was reported that the pt developed a rash after being exposed to the chicken pox. It was reported that the rash did not look like a "typical" varicella rash and it was noted that the child did not develop any other symptoms such as fever. The pt had not yet been seen by a doctor. Follow-up info stated that the reporter was concerned about a 'breakthrough rash years after the vaccine, when a child is exposed, and not a vaccine reaction." No further info is expected.
Severe Vertigo happened on 4/22/2022. Vertigo was so bad that I couldn't walk, drive, etc. Tried to manage symptoms by taking Sudafed, but needed to take more than the package allowed in order to help. I assumed that it was related to my springtime allergies to tree pollen (which had been VERY high in the previous two weeks, but was much lower when the vertigo started). I started throwing up on Sunday, 4/24. I saw my primary care physician on 4/25 and she could find no apparent cause for it. She gave me a prescription for meclizine and suggested that I start Flonase. She also had me try the modified Semont maneuver for self-treatment of Benign Positional Vertigo (which has helped somewhat). I am better, but still not fully functional.
Acute Covid Symptoms.  Headache, eye pain, neck pain, back pain, chest pain, vertigo, nausea, energy loss, throat irritation, cough.  102 fever for 8 hours, with chills, sweats, and delusional visions.  Elevated temperature 99.8 for 48hours with continued cough, eye pain, chest pain.  Continued swollen lymph nodes under arms, confused/ cloudy cognitive function, chest pain, energy loss, light sensitivity and measurable vision loss in right eye.
Note from observer, RN: 0836am at 15 min. check patient with complaint of some slight chest pressure while in observation post COVID Vaccination. States this has happened previously with nervousness during vaccinations. At time of discussion reports pressure was better. BP 127/79/Pulse 70. Denies symptoms at this time. Patient agreed to remain additional 15 min. At 0851 am, patient denies any symptoms. At 0852 ampatient left on own.
A weird slight metallic taste; Slight numbness in the injection site; A spontaneous report was received from a 31 year old female patient (other health care professional) concerning herself who participated in the mRNA-1273 Emergency Use Program and experienced slight numbness in the injection site arm and a weird slight metallic taste.  The patient's medical history was not provided. No relevant concomitant medications were reported.   On 04 Jan 2021 at two-thirty pm, the patient received their first of two planned doses of mRNA-1273 (post-meridiem) intramuscularly in the right arm for prophylaxis of COVID-19 infection.   On 04 Jan 2021, 15 minutes after receiving the first dose of mRNA-1273,the patient noticed slight numbness in the injection site arm and a weird slight metallic taste. The patient gave consent to follow up from safety.  No treatment information was provided.   Action taken with mRNA-1273 in response to the events was not reported.   The outcome of the events were not reported.   The reporter did not provide an assessment for the events, slight numbness in the injection site arm and a weird slight metallic taste.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.